It amazes me how people are already claiming this is another BS even without the results having been released.
They've gone towards making partnerships for commercialization already. This won't be a cheap topical, it's a synthetic antibody that will cost 1000s of dollars. Going mass production without solid background that it works is a suicide.
Moreover, the most interesting thing is to prove that the PRLR is one of the main mediators. Supposed this premise is proven true, this opens up new research that will have much better odds to yield reliable treatments than the current approaches.
If HMI is a viable product for endometriosis, then that alone justifies the up-front investment to mass-produce it. And that will cheapen the stuff to some extent.
But if the drug doesn't regrow any more hair than this 'Moeman' trialist shows, then it's fair to call it another frustrating disappointment. We didn't start paying attention to this stuff hoping for another Propecia. We were hoping for some actual progress and the macaque results seemed to promise that.
If HMI is another Propecia then I'm glad to have it and I'm also really f*****g disappointed that it wasn't more. Anybody who gripes at other forum members for that attitude has no emotional intelligence. Hair loss treatments are not sports teams. It's ridiculous the way people get so tribal about them around here. (FFS, you'd think going bald would have some correlation with maturity.)
Bottom line - we still don't know the situation with HMI until we see the data results from the stage-2 trial.